<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Rheumatology</title>
            <link>https://medicalxpress.com/rheumatology-news/</link>
            <language>en-us</language> 
            <description>Latest medical news and research in Rheumatology</description>

                            <item>
                    <title>Therapy program for kids with lupus can change lives in 6 sessions</title>
                    <description>Often diagnosed in the teenage years, childhood-onset lupus is a serious, potentially fatal autoimmune disease that causes the body to attack itself. For as many as 10,000 U.S. youths, it can bring extreme fatigue, mood changes, pain and inflammation that affect many parts of the body.</description>
                    <link>https://medicalxpress.com/news/2026-04-therapy-kids-lupus-sessions.html</link>
                    <category></category>
                    <pubDate>Sat, 18 Apr 2026 13:00:02 EDT</pubDate>
                    <guid isPermaLink="false">news695564219</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/therapy-program-for-ki.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Decade‑long wait for specialist NHS rheumatology referral from Wales to England reported</title>
                    <description>New research from Swansea University has identified significant delays and diagnostic barriers affecting rheumatology patients in Wales. The study is published in the Journal of Patient Experience.</description>
                    <link>https://medicalxpress.com/news/2026-04-decadelong-specialist-nhs-rheumatology-referral.html</link>
                    <category></category>
                    <pubDate>Fri, 17 Apr 2026 10:00:05 EDT</pubDate>
                    <guid isPermaLink="false">news695637721</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/rheumatology.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>GLP-1 in joint fluid may let weight-loss drugs target arthritis directly</title>
                    <description>Arthritis includes a range of conditions that affect the joints, from inflammatory diseases such as rheumatoid arthritis and psoriatic arthritis to more common conditions like osteoarthritis. Many people experience pain, stiffness, and a reduced quality of life. Treatment today focuses on reducing inflammation and relieving symptoms, depending on the type of arthritis. However, researchers from the Department of Biomedicine at Aarhus University have now identified a new possible route for future treatments. Their research is published in The Lancet Rheumatology journal.</description>
                    <link>https://medicalxpress.com/news/2026-04-glp-joint-fluid-weight-loss.html</link>
                    <category></category>
                    <pubDate>Thu, 16 Apr 2026 16:00:05 EDT</pubDate>
                    <guid isPermaLink="false">news695569381</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/arthritis.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>This laser breakthrough supercharges osteoporosis treatment by exposing bone&#039;s hidden growth switch</title>
                    <description>A research team has discovered a new mechanism and drug combination strategy that can effectively treat osteoporosis, a representative disease of super-aging societies. The research findings were published on April 2 in Bone Research. The researchers were led by Seoul National University College of Engineering&#039;s Prof. Sunghoon Kwon and Prof. Sang Wan Kim.</description>
                    <link>https://medicalxpress.com/news/2026-04-laser-breakthrough-supercharges-osteoporosis-treatment.html</link>
                    <category></category>
                    <pubDate>Tue, 14 Apr 2026 14:40:04 EDT</pubDate>
                    <guid isPermaLink="false">news695394053</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/snu-engineeringmedical.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>PEPITEM &#039;replacement therapy&#039; shows potential for early-stage inflammatory arthritis</title>
                    <description>Scientists investigating the naturally occurring immunopeptide PEPITEM have shown reductions in arthritic joint swelling to a degree comparable to the current standard of care, and reduce the inflammatory changes that cause joint damage.</description>
                    <link>https://medicalxpress.com/news/2026-04-pepitem-therapy-potential-early-stage.html</link>
                    <category></category>
                    <pubDate>Mon, 13 Apr 2026 04:00:02 EDT</pubDate>
                    <guid isPermaLink="false">news695035561</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/wrist-pain.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Nerve growth factor alone triggers osteoarthritis-like joint changes in healthy mice</title>
                    <description>Nerve growth factor (NGF) is a specialized protein, also called a neurotrophin, that is critical for the development and survival of nerves responsible for our senses and the body&#039;s fight-or-flight response. While the presence of NGF is crucial during the embryonic stage, its presence in adults is often an indication of inflammation, as it is a key mediator of pain for conditions like osteoarthritis (OA). Now, a study published in Arthritis &amp; Rheumatology shows that NGF is much more than a pain messenger—it can actually change the structure of a joint.</description>
                    <link>https://medicalxpress.com/news/2026-04-nerve-growth-factor-triggers-osteoarthritis.html</link>
                    <category></category>
                    <pubDate>Sun, 12 Apr 2026 11:00:02 EDT</pubDate>
                    <guid isPermaLink="false">news694867180</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/nerve-growth-factor-al.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>How an overactive immune system can drive cancer</title>
                    <description>The immune system is designed to protect us against viruses and bacteria. In autoimmune diseases, however, the immune system instead attacks the body&#039;s own cells. Conditions such as systemic lupus erythematosus (lupus) and rheumatoid arthritis are well-known examples. It is estimated that just under 250,000 people in Norway live with some form of autoimmune disease, with approximately 8% to 10% of the population worldwide.</description>
                    <link>https://medicalxpress.com/news/2026-04-overactive-immune-cancer.html</link>
                    <category></category>
                    <pubDate>Thu, 09 Apr 2026 13:20:03 EDT</pubDate>
                    <guid isPermaLink="false">news694958762</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/how-an-overactive-immu-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>CAR-T therapy drives remission in patient with three autoimmune diseases</title>
                    <description>For the first time, scientists have used a modern cell therapy called CAR-T to treat a patient with three different life-threatening autoimmune diseases that had resisted years of treatment. The patient, who once required daily blood infusions, has been in remission without needing additional treatment for a year since the CAR-T therapy. The case report, published in Med, suggests that CAR-T therapies can help treat complex and severe autoimmune diseases.</description>
                    <link>https://medicalxpress.com/news/2026-04-car-therapy-remission-patient-autoimmune.html</link>
                    <category></category>
                    <pubDate>Thu, 09 Apr 2026 11:00:04 EDT</pubDate>
                    <guid isPermaLink="false">news694881961</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/car-t-therapy-drives-r.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Scientists test new ways to regrow joints damaged by arthritis</title>
                    <description>Good news: Scientists may be closer to a new way to treat arthritis.</description>
                    <link>https://medicalxpress.com/news/2026-04-scientists-ways-regrow-joints-arthritis.html</link>
                    <category></category>
                    <pubDate>Tue, 07 Apr 2026 16:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news694783635</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/scientists-test-new-wa.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>AAD: Significant benefits seen for brepocitinib 30 mg in dermatomyositis</title>
                    <description>For adults with dermatomyositis, brepocitinib, an oral tyrosine kinase 2/Janus kinase 1 inhibitor, demonstrates significant benefits at a 30-mg dose compared with placebo, according to a study published online March 28 in the New England Journal of Medicine to coincide with the annual meeting of the American Academy of Dermatology, held from March 27 to 31 in Denver.</description>
                    <link>https://medicalxpress.com/news/2026-04-aad-significant-benefits-brepocitinib-mg.html</link>
                    <category></category>
                    <pubDate>Wed, 01 Apr 2026 16:10:07 EDT</pubDate>
                    <guid isPermaLink="false">news694274982</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/aad-significant-benefi.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Cancer risk rises with autoimmune disorders but drops after anti-inflammatory therapy, finds study</title>
                    <description>When patients start getting treated for conditions like psoriatic arthritis, or connective tissue diseases like lupus and systemic sclerosis, their heightened risk of cancer gradually decreases, according to a new five-year study tracking people with immune-mediated inflammatory diseases (IMID). Scientists theorize that the anti-inflammatory treatment for these diseases provides potential protective effects, reversing the increased cancer risk caused by high inflammation.</description>
                    <link>https://medicalxpress.com/news/2026-03-cancer-autoimmune-disorders-anti-inflammatory.html</link>
                    <category></category>
                    <pubDate>Tue, 31 Mar 2026 14:30:03 EDT</pubDate>
                    <guid isPermaLink="false">news694185721</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/cancer-tumor.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Scientists pinpoint a skin alarm system pathway that links local damage to systemic immune responses</title>
                    <description>Skin, our largest organ, acts as a protective barrier against pathogens that try to invade our bodies while constantly monitoring for potential threats. In the skin&#039;s outermost layer, the epidermis, reside keratinocytes, cells that detect danger and actively orchestrate the body&#039;s immune response. How these cells perform this task in a localized manner and then communicate the message with the entire immune system had been a mystery, but now a team of researchers from China has uncovered the signaling pathway.</description>
                    <link>https://medicalxpress.com/news/2026-03-scientists-skin-alarm-pathway-links.html</link>
                    <category></category>
                    <pubDate>Mon, 23 Mar 2026 10:20:04 EDT</pubDate>
                    <guid isPermaLink="false">news693479936</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/scientists-pinpoint-a-2.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>An immune signaling pathway drives pain in arthritis, researchers discover</title>
                    <description>Rheumatoid arthritis is a chronic autoimmune disease that affects millions of people worldwide. This disease prompts the immune system to mistakenly attack body tissues, particularly joints, leading to inflammation, swelling, stiffness and pain.</description>
                    <link>https://medicalxpress.com/news/2026-03-immune-pathway-pain-arthritis.html</link>
                    <category></category>
                    <pubDate>Fri, 20 Mar 2026 13:40:03 EDT</pubDate>
                    <guid isPermaLink="false">news693227000</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/a-newly-discovered-sig.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Botox: A new therapeutic approach to treating finger ulcers and gangrene</title>
                    <description>Injections of botulinum toxin, commonly known as Botox, could be an effective and well-tolerated option for treating debilitating complications caused by reduced blood flow to the fingers, such as acute digital ischemia (which makes the fingers very painful, cold and sometimes white or bluish), digital ulcers (open wounds that heal poorly), and gangrene, according to a study recently published in JAMA Dermatology.</description>
                    <link>https://medicalxpress.com/news/2026-03-botox-therapeutic-approach-finger-ulcers.html</link>
                    <category></category>
                    <pubDate>Fri, 20 Mar 2026 11:20:01 EDT</pubDate>
                    <guid isPermaLink="false">news693221281</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/hand.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Key protein found to protect cartilage, offering new hope for osteoarthritis treatment</title>
                    <description>Osteoarthritis, a condition that causes pain and reduced mobility in joints such as the knees and fingers, is one of the most common joint disorders worldwide, particularly among aging populations. The disease is characterized by the gradual breakdown of cartilage, which normally cushions the bones within joints.</description>
                    <link>https://medicalxpress.com/news/2026-03-key-protein-cartilage-osteoarthritis-treatment.html</link>
                    <category></category>
                    <pubDate>Fri, 20 Mar 2026 10:40:01 EDT</pubDate>
                    <guid isPermaLink="false">news693221162</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/shp-protein-found-to-p.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Musculoskeletal disorders are shortening healthy working lives across Europe, researchers say</title>
                    <description>Rheumatic and musculoskeletal disorders (RMDs) like arthritis are having a significant impact on how long people across Europe can remain healthy while working, according to a new study. A research team from Keele University has found that workers in European countries who have an RMD can expect to be healthy and in work for significantly less time than their counterparts who do not have one of these conditions, with the difference being as much as 50% in six of the countries studied.</description>
                    <link>https://medicalxpress.com/news/2026-03-musculoskeletal-disorders-shortening-healthy-europe.html</link>
                    <category></category>
                    <pubDate>Tue, 17 Mar 2026 16:10:06 EDT</pubDate>
                    <guid isPermaLink="false">news692981522</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/musculoskeletal-disord.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Why arthritis in children can threaten eyesight</title>
                    <description>Arthritis is often associated with older age, but it also affects children. One of the most common forms is juvenile idiopathic arthritis (JIA), an inflammatory condition that causes persistent joint swelling and pain.</description>
                    <link>https://medicalxpress.com/news/2026-03-arthritis-children-threaten-eyesight.html</link>
                    <category></category>
                    <pubDate>Tue, 17 Mar 2026 13:40:06 EDT</pubDate>
                    <guid isPermaLink="false">news692971861</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2019/7-eye.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Study finds online Pilates program helps people with hypermobile Ehlers-Danlos syndrome</title>
                    <description>Research at Clarkson University is helping people with hypermobile Ehlers-Danlos syndrome (hEDS) move with less pain and more confidence. The study, published in the Journal of Multidisciplinary Healthcare, looked at whether an eight-week, online Pilates program could help people with symptomatic joint hypermobility. The program was designed specifically for people with hEDS, a condition that can cause joint pain, fatigue and fear of movement.</description>
                    <link>https://medicalxpress.com/news/2026-03-online-pilates-people-hypermobile-ehlers.html</link>
                    <category></category>
                    <pubDate>Tue, 17 Mar 2026 10:10:02 EDT</pubDate>
                    <guid isPermaLink="false">news692960762</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/pilates-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Nine years to diagnosis: The challenge of spotting inflammatory arthritis and the role of first contact physiotherapists</title>
                    <description>Joint pain is often dismissed as aging, overuse or a minor injury. But for some people it is the first sign of inflammatory arthritis, a group of immune-driven conditions that can damage joints and other organs if not treated promptly.</description>
                    <link>https://medicalxpress.com/news/2026-03-years-diagnosis-inflammatory-arthritis-role.html</link>
                    <category></category>
                    <pubDate>Sat, 14 Mar 2026 09:30:01 EDT</pubDate>
                    <guid isPermaLink="false">news692371737</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/arthritis-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Gut health supplement relieves arthritis pain, finds new study</title>
                    <description>A new study has found that a prebiotic fiber supplement reduced pain, improved grip strength, and lowered pain sensitivity in people with knee osteoarthritis (OA)—with far fewer dropouts than a digital physiotherapy program. The INSPIRE clinical trial, led by experts at the University of Nottingham, showed that taking a daily supplement of inulin—a natural dietary fiber found in chicory root, Jerusalem artichokes and other vegetables—significantly reduced pain in people with OA.</description>
                    <link>https://medicalxpress.com/news/2026-03-gut-health-supplement-relieves-arthritis.html</link>
                    <category></category>
                    <pubDate>Thu, 12 Mar 2026 21:10:01 EDT</pubDate>
                    <guid isPermaLink="false">news692528210</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/gut-health-supplement.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>FDA provides fast track designation to nipocalimab for systemic lupus erythematosus</title>
                    <description>Johnson &amp; Johnson&#039;s nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE).</description>
                    <link>https://medicalxpress.com/news/2026-03-fda-fast-track-nipocalimab-lupus.html</link>
                    <category></category>
                    <pubDate>Thu, 12 Mar 2026 19:50:02 EDT</pubDate>
                    <guid isPermaLink="false">news692522383</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/fda-provides-fast-trac.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>FDA approves Sotyktu for adults with active psoriatic arthritis</title>
                    <description>The U.S. Food and Drug Administration has approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.</description>
                    <link>https://medicalxpress.com/news/2026-03-fda-sotyktu-adults-psoriatic-arthritis.html</link>
                    <category></category>
                    <pubDate>Wed, 11 Mar 2026 14:40:05 EDT</pubDate>
                    <guid isPermaLink="false">news692455194</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/fda-approves-sotyktu-f.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Approved IV drug reduces lupus symptoms, clinical trial finds</title>
                    <description>An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant improvement in their symptoms after a year on the drug, researchers report in The New England Journal of Medicine.</description>
                    <link>https://medicalxpress.com/news/2026-03-iv-drug-lupus-symptoms-clinical.html</link>
                    <category></category>
                    <pubDate>Tue, 10 Mar 2026 17:00:04 EDT</pubDate>
                    <guid isPermaLink="false">news692354707</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/approved-iv-drug-reduc.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Targeted PET/CT predicts early treatment response in rheumatoid arthritis patients</title>
                    <description>A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research published in The Journal of Nuclear Medicine. Compared to the three to six months currently required to establish treatment efficacy, this new imaging technique could help determine the patients who are most likely to respond sooner, allowing non-responders to pursue more effective therapies.</description>
                    <link>https://medicalxpress.com/news/2026-03-petct-early-treatment-response-rheumatoid.html</link>
                    <category></category>
                    <pubDate>Mon, 02 Mar 2026 12:40:01 EST</pubDate>
                    <guid isPermaLink="false">news691676821</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/targeted-petct-predict.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Why is gout on the rise?</title>
                    <description>A condition once called the &quot;disease of kings&quot; is affecting even the general population. Rates of gout, a type of inflammatory arthritis that causes severe, sudden stabbing pain in the big toe, have increased by more than 20% since 1990. Even though it&#039;s becoming a more widespread condition, gout still carries the public perception that has sometimes oversimplified gout as a lifestyle-driven disease.</description>
                    <link>https://medicalxpress.com/news/2026-03-gout.html</link>
                    <category></category>
                    <pubDate>Mon, 02 Mar 2026 10:20:07 EST</pubDate>
                    <guid isPermaLink="false">news691667882</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/foot-pain.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Multidisciplinary study uses blood samples to identify diseases years before they start</title>
                    <description>What if doctors could tell you a disease was coming years before you felt a single symptom—and stop it in its tracks? That is the goal of a sweeping new research initiative launched by the Icahn School of Medicine at Mount Sinai in collaboration with the Uniformed Services University of the Health Sciences (USU) and the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF).</description>
                    <link>https://medicalxpress.com/news/2026-03-multidisciplinary-blood-samples-diseases-years.html</link>
                    <category></category>
                    <pubDate>Mon, 02 Mar 2026 09:20:03 EST</pubDate>
                    <guid isPermaLink="false">news691665302</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2018/1-bloodsample.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Dry eye often precedes autoimmune disease diagnosis, new study finds</title>
                    <description>Frequent dry eyes may signal more than simple irritation and could be an early warning sign of an autoimmune disease. This symptom has long been associated with Sjögren&#039;s Disease, a chronic autoimmune condition in which the immune system mistakenly attacks the tear ducts and salivary glands, causing inflammation that leads to dry eyes and dry mouth. Now, a study of 67,264  patients in Taiwan with autoimmune diseases found that dry eye disease (DED) preceded the autoimmune diagnosis by about three years.</description>
                    <link>https://medicalxpress.com/news/2026-02-dry-eye-autoimmune-disease-diagnosis.html</link>
                    <category></category>
                    <pubDate>Wed, 25 Feb 2026 11:20:04 EST</pubDate>
                    <guid isPermaLink="false">news691236263</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/dry-eye-often-precedes.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>These shoes are best for hip and knee arthritis, according to science</title>
                    <description>People with hip and knee osteoarthritis are advised to wear &quot;appropriate footwear&quot; to minimize their pain. Does that mean heels are out? Does it matter if you wear runners or something a little stiffer? How about using insoles?</description>
                    <link>https://medicalxpress.com/news/2026-02-hip-knee-arthritis-science.html</link>
                    <category></category>
                    <pubDate>Tue, 24 Feb 2026 21:30:01 EST</pubDate>
                    <guid isPermaLink="false">news691152603</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/red-heels.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Is exercise overrated for osteoarthritis? What the latest evidence suggests</title>
                    <description>The effectiveness of exercise therapy to ease the symptoms of osteoarthritis is likely minimal, short lived, and probably no better than no treatment at all, suggests an overarching (umbrella) systematic review and pooled data analysis of the available evidence, published in the open access journal RMD Open.</description>
                    <link>https://medicalxpress.com/news/2026-02-overrated-osteoarthritis-latest-evidence.html</link>
                    <category></category>
                    <pubDate>Tue, 17 Feb 2026 18:30:06 EST</pubDate>
                    <guid isPermaLink="false">news690484201</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/treadmill-walk.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Predicting and preventing the risk of hip fracture related to osteoporosis</title>
                    <description>Researchers at Pompeu Fabra University (UPF) have made a great leap toward predicting the risk of hip fracture among people with osteoporosis and evaluating the effectiveness of specific drugs to prevent it. The BCN Med Tech Unit of the UPF Department of Engineering, together with the company 3D-Shaper Medical, have developed two leading studies in which they present a new computational system to predict and prevent the risk of hip fracture far more precisely than the most common clinical methods today.</description>
                    <link>https://medicalxpress.com/news/2026-02-hip-fracture-osteoporosis.html</link>
                    <category></category>
                    <pubDate>Tue, 17 Feb 2026 16:26:45 EST</pubDate>
                    <guid isPermaLink="false">news690567962</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/researchers-from-upf-a-1.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
